CAR T-Cell-Related Encephalopathy Syndrome
3 clinical trials · Condition
◉ Watch CAR T-Cell-Related Encephalopathy Syndrome
| Record | Firm | Date |
|---|---|---|
| CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia (NCT05043571) | National University Hospital, Singapore | 2021-09-08 |
| ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. (NCT05038696) | National University Hospital, Singapore | 2021-04-28 |
| Multicenter Study Using IMC to Analyze the Impact of ICANS on Microglia (NCT05811117) | University of Freiburg | 2021-04-12 |
Track CAR T-Cell-Related Encephalopathy Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.